The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study-Reference-Cited by-同舟云学术

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

Published:2008-04 Issue:4 Volume:30 Page:587-604
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Chrysant Steven G.,Melino Michael,Karki Sulekha,Lee James,Heyrman Reinilde

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference36 articles.

1. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004;Ong;Hypertension,2007

2. Recent changes in cardiovascular risk factors among women and men;Kim;J Womens Health (Larchmt),2006

3. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies;Lewington;Lancet,2002

4. Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension;Lopez;J Clin Hypertens (Greenwich),2007

5. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals;Okonofua;Hypertension,2006

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients;Frontiers in Pharmacology;2024-08-28

2. Personalized Antihypertensive Treatment Optimization With Smartphone‐Enabled Remote Precision Dosing of Amlodipine During the COVID‐19 Pandemic (PERSONAL‐CovidBP Trial);Journal of the American Heart Association;2024-02-20

3. Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar^®) in older patients with essential hypertension: Subgroup analysis from the Sevikar study;Experimental and Therapeutic Medicine;2023-12-05

4. The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1};Trials;2023-11-28

5. Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation;Journal of Nuclear Cardiology;2023-08